High-dose chromic picolinate treatment of type II diabetes
Patent 6329361 Issued on December 11, 2001. Estimated Expiration Date: 
December 11, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 11, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesDietary supplementation with essential metal picolinates Chromic picolinate treatment Anabolic mineral formula Patent #: 5164384 InventorAssigneeApplicationNo. 440362 filed on 05/12/1995US Classes:514/188, Hetero ring is six-membered consisting of one nitrogen and five carbons514/505, Cadmium or chromium514/866DIABETESExaminersPrimary: Goldberg, Jerome D.Attorney, Agent or FirmInternational ClassesA61K 031/555A61K 031/28 AbstractA method for stabilizing blood glucose levels and reducing the hyperglycemia associated with Type II diabetes. Synthetic chromic tripicolinate is administered either orally or parenterally to a human in need thereof at a dosage of between about 1,000 amd 10,000 micrograms per day.Other References
| |
